Top compounds associated with response to SLC22A13


Feature Type Standardized
Nominal ANOVA
mRNA Bexarotene GDSC1000 pan-cancer AAC -0.047 0.2
mRNA KPT185 CTRPv2 pan-cancer AAC -0.053 0.2
mRNA NU-7441 GDSC1000 pan-cancer AAC -0.047 0.2
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.048 0.2
mRNA BRD-K51831558 CTRPv2 pan-cancer AAC 0.073 0.2
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC -0.05 0.2
mRNA ML311 CTRPv2 pan-cancer AAC -0.045 0.2
mRNA simvastatin CTRPv2 pan-cancer AAC 0.054 0.2
mRNA nintedanib CTRPv2 pan-cancer AAC -0.051 0.2
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.049 0.2
Download CSV